Surya Pharmaceutical Limited, a under liquidation public limited company, was established on 25 March 1992 in Delhi, Delhi, India. Engaging in ayurvedic products & services within the healthcare sector, it holds CIN: L24232DL1992PLC227186. Registered under ROC Roc Delhi. it is listed. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹20.28 Cr.
It upholds a active non-compliant status. Its leadership includes Bharat Bhushan Jain (Company Secretary), Jasvinder Singh (Additional Director), Rajiv Goyal (Managing Director). Past directors included Manohar Lal Sharma, Haribhajan Lal Vohra, Abhishek Arya. It holds ₹4,828.13 Cr open charges and ₹1,682.69 Cr settled loans. Its latest AGM occurred on 29 September 2014, with the balance sheet filed on 31 March 2014. It is based at 1596 , 1St Floor Bhagirath Palace , Chandni Chownk, Delhi, Delhi, 110006.
L24232DL1992PLC227186
227186
25 March 1992
₹100.00 Cr
₹20.28 Cr
Roc Delhi
Listed
Under Liquidation
Explore comprehensive insights into Surya Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharat Bhushan Jain | Company Secretary | 16 Jun 2012 | Current |
| Jasvinder Singh | Additional Director | 10 Oct 2013 | Current |
| Rajiv Goyal | Managing Director | 25 Mar 1992 | Current |
| Alka Goyal | Whole-Time Director | 24 Aug 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jul 2011 | Past |
| Pramod Abcsdd | Director | 04 Mar 2012 | Past |
| Pramod Abcsdd | Additional Director | 20 Sep 2008 | Past |
| Pramod Abcsdd | Director | 12 Nov 2011 | Past |
| Pramod Abcsdd | Nominee Director | 24 Dec 2010 | Past |
| Pramod Abcsdd | Director | 30 Nov 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Surya Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Surya Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹48,281,300,000.00
₹16,826,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2013 | State Bank Of India | ₹546.44 Cr | Open |
| 31 Dec 2012 | Punjab National Bank | ₹135.99 Cr | Open |
| 14 Feb 2012 | Idbi Bank Limited | ₹60.00 Cr | Open |
| 05 Jan 2012 | Punjab National Bank | ₹5.00 Cr | Open |
| 02 Nov 2011 | Punjab National Bank | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Surya Pharmaceutical has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Surya Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Surya Pharmaceutical Limited last Annual general meeting of members was held on 29 Sep 2014 as per latest MCA records. was documented.
Progress on Surya Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was documented.
The activity A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 2.50 Cr registered on 12 Nov 2008 with Charge ID 10132676 was modified on 26 Mar 2014. was completed.
Progress on A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 3.00 Cr registered on 20 Sep 2007 with Charge ID 10068728 was modified on 26 Mar 2014. was documented.
The activity A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 100.00 Cr registered on 13 Oct 2004 with Charge ID 90312128 was modified on 26 Mar 2014. was completed.
Progress on A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 30.00 Cr registered on 19 Jan 2011 with Charge ID 10260867 was modified on 31 Dec 2013. was documented.
The CIN of Surya Pharmaceutical Limited is L24232DL1992PLC227186.
Surya Pharmaceutical Limited is headquartered at 1596 , 1St Floor Bhagirath Palace , Chandni Chownk, Delhi, Delhi, 110006.
Surya Pharmaceutical Limited was incorporated on 25 March 1992.
The current directors of Surya Pharmaceutical Limited are
The primary industry of Surya Pharmaceutical Limited is Healthcare.
Surya Pharmaceutical Limited is listed.
The authorized capital of Surya Pharmaceutical Limited is ₹100.00 Cr, and the paid-up capital is ₹20.28 Cr.
The compliance status of Surya Pharmaceutical Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX